Ingevity CorporationNGVTNYSE
Loading
EBITDA Over TimeContracting
Percentile Rank8
3Y CAGR-63.8%
5Y CAGR-44.1%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-63.8%/yr
vs +8.3%/yr prior
5Y CAGR
-44.1%/yr
Recent deceleration
Acceleration
-72.2pp
Decelerating
Percentile
P8
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$20.80M+106.3%
2024$-329.50M-260.0%
2023$206.00M-53.2%
2022$440.20M+35.7%
2021$324.40M-15.2%
2020$382.40M-7.4%
2019$412.90M+29.1%
2018$319.80M+31.6%
2017$243.10M+22.0%
2016$199.20M-